The present study puts forth a standardized in vitro TCP assay for biofilm biomass quantitation and categorization criteria for clinical isolates of S. aureus based on their biofilm-forming capacity. The proposed in vitro technique may be further evaluated for its usefulness in the management of persistent infections caused by the bacterium.
No takes yet. Share an insight, caveat, or question.
Prakash et al. (2017) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: